Article Information
History
- April 22, 2022.
Article Versions
- Version 1 (April 11, 2022 - 13:30).
- Version 2 (April 21, 2022 - 09:01).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Snežana Medić1,2,
- Cleo Anastassopoulou3,
- Zagorka Lozanov-Crvenković4,
- Vladimir Vuković1,2,
- Nataša Dragnić5,
- Vladimir Petrović1,2,
- Mioljub Ristić1,2,
- Tatjana Pustahija1,2,
- Zoran Gojković2,6,
- Athanasios Tsakris3 and
- John P. A. Ioannidis7,*
- 1Center for Disease Control and Prevention, Institute of Public Health of Vojvodina, Novi Sad, Serbia
- 2Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia
- 3Department of Microbiology, Medical School, National and Kapodistrian University of Athens, Athens, Greece
- 4Department of Mathematics and Informatics, Faculty of Science, University of Novi Sad, Novi Sad, Serbia
- 5Center for Informatics and Biostatistics, Institute of Public Health of Vojvodina, Novi Sad, Serbia
- 6Clinical Center of Vojvodina, Novi Sad, Serbia
- 7Departments of Medicine, Epidemiology and Population Health, Biomedical Data Science, and Statistics, Stanford University, Stanford, USA
- ↵*Corresponding author: E-mail: jioannid{at}stanford.edu (JPAI)
Posted April 22, 2022.
Risk and severity of SARS-CoV-2 reinfections during 2020-2022 in Vojvodina, Serbia: a population-level study
